Laiman Xiang

Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.

Liang Xu, Chengcheng Huang, Wei‐Qun Huang et al. · PubMed · 2002 · 246 citations

Pharmacy, Oncology, Pharmaceutics +17

An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes

Masanori Onda, Richard Beers, Laiman Xiang et al. · Proceedings of the National Academy of Sciences · 2008 · 165 citations · Full text

Life Sciences, Immunology, Oncology +15

A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity

John E. Weldon, Laiman Xiang, Oleg Chertov et al. · Blood · 2008 · 164 citations · Full text

Medicine, Immunology, Toxicology +4

Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes

Wenhai Liu, Masanori Onda, Robert J. Kreitman et al. · Proceedings of the National Academy of Sciences · 2012 · 158 citations · Full text

Life Sciences, Immunology, Oncology +17

Systemic p53 Gene Therapy of Cancer with Immunolipoplexes Targeted by Anti-Transferrin Receptor scFv

Liang Xu, Wenhua Tang, Chengcheng Huang et al. · Molecular Medicine · 2001 · 148 citations · Full text

Pharmacy, Molecular Pharmaceutics, Oncology +17